{
    "clinical_study": {
        "@rank": "93985", 
        "arm_group": [
            {
                "arm_group_label": "CVT-301", 
                "arm_group_type": "Experimental", 
                "description": "CVT-301 at Dose Level 1 for 1st 14 days of treatment then increased to Dose level 2 for last 14 days of treatment"
            }, 
            {
                "arm_group_label": "Inhaled Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized, multicenter, placebo-controlled, double-blind study will evaluate the\n      efficacy and safety of inhaled CVT 301 compared with placebo in PD patients experiencing\n      motor response fluctuations (OFF phenomena) as an outpatient (i.e., at home) and in the\n      clinic."
        }, 
        "brief_title": "Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Idiopathic Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Idiopathic Parkinson's Disease (PD) diagnosed between the ages of 30 and 80 years;\n\n          -  Hoehn and Yahr Stage 1-3 in an \"on\" state;\n\n          -  Require levodopa-containing medication regimen at least 4 times during the waking\n             day;\n\n          -  Experience motor fluctuations with a minimum of 2 hours of average daily \"off\" time\n             per waking day (excluding early morning \"off\" time) and demonstrate levodopa\n             responsiveness;\n\n          -  Are on stable PD medication regimen.\n\n        Exclusion Criteria:\n\n          -  Pregnant or lactating females;\n\n          -  Previous surgery for PD or plan to have stereotactic surgery during the study period;\n\n          -  History of psychotic symptoms requiring treatment, or suicide ideation or attempt\n             within last year;\n\n          -  Adequate lung function as measured by spirometry;\n\n          -  Any significant condition, severe concurrent disease, abnormality or finding that\n             would make patients unsuitable or may compromise patient safety."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "89", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01777555", 
            "org_study_id": "CVT-301-003", 
            "secondary_id": "2012-005822-31"
        }, 
        "intervention": [
            {
                "arm_group_label": "CVT-301", 
                "intervention_name": "CVT-301", 
                "intervention_type": "Drug", 
                "other_name": "Levodopa Inhalation Powder"
            }, 
            {
                "arm_group_label": "Inhaled Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Levodopa"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Parkinson's Disease", 
            "Motor fluctuations", 
            "levodopa", 
            "inhaled drugs", 
            "Off episodes"
        ], 
        "lastchanged_date": "April 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas"
                    }, 
                    "name": "Civitas Investigational Site 1013"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boca Raton", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Civitas Investigational Site 1004"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Charlotte", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Civitas Investigational Site 1002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Civitas Investigational Site 1015"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas"
                    }, 
                    "name": "Civitas Investigational Site 1007"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "Civitas Investigational Site 1010"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bingham Farms", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Civitas Investigational Site 1001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roseville", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Civitas Investigational Site 1008"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Civitas Investigational Site 1009"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Bloomfield", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Civitas Investigational Site 1005"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kingston", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Civitas Investigational Site 1011"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Civitas Investigational Site 1014"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kirkland", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "Civitas Investigational Site 1003"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cassino", 
                        "country": "Italy"
                    }, 
                    "name": "Civitas Investigational Site 4003"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chieti", 
                        "country": "Italy"
                    }, 
                    "name": "Civitas Investigational Site 4002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy"
                    }, 
                    "name": "Civitas Investigational Site 4001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belgrade", 
                        "country": "Serbia"
                    }, 
                    "name": "Civitas Investigational Site 3001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belgrade", 
                        "country": "Serbia"
                    }, 
                    "name": "Civitas Investigational Site 3002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cambridge", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Civitas Investigational Site 2004"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Civitas Investigational Site 200"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Civitas Investigational Site 2001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stoke on Trent", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Civitas Investigational Site 2003"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Italy", 
                "Serbia", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Inhaled CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)", 
        "overall_official": {
            "affiliation": "Civitas Therapeutics", 
            "last_name": "Martin Freed, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Serbia and Montenegro: Agency for Drugs and Medicinal Devices", 
                "Italy: The Italian Medicines Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in average Unified Parkinson's Disease Rating Scale Part III motor score", 
            "safety_issue": "No", 
            "time_frame": "pre-dose to 60 minutes following treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01777555"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Time to resolution of OFF episode to an ON state.", 
                "safety_issue": "No", 
                "time_frame": "28 days duration outpatient treatment"
            }, 
            {
                "description": "Adverse experiences, ECGs, vital signs, clinical laboratory evaluation, pulmonary function using spirometry", 
                "measure": "To characterize the safety (including pulmonary safety)of CVT-301 when used chronically to provide relief from OFF episodes.", 
                "safety_issue": "Yes", 
                "time_frame": "change from baseline through 28 days outpatient use"
            }
        ], 
        "source": "Civitas Therapeutics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Civitas Therapeutics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}